Access samples and data collected and generated by the HoloFood project.
Data available for SAMEA112949433
Metadata for sample SAMEA112949433, stored in BioSamples.
Download all as TSVMarker | Measurement | Units |
---|---|---|
Animal code | SC02.04 | None |
Organism | Salmon | None |
Project | HoloFood | None |
Salmon body length | 10.2 | cm |
Salmon gutted weight | 10.8 | g |
Salmon live weight | 13.4 | g |
Sampling time | Day 0 | None |
Wound | NO | None |
Marker | Measurement | Units |
---|---|---|
Average end weight | 53.04 | g |
Average start weight | 16.24 | g |
End of sampling (No. of fish) | 20 | None |
Feed conversion ratio | 0.7 | feed mass/fish weight gain |
Mid sampling (No. of fish) | 6 | None |
Mortality (No. of fish) | 2 | None |
Standard growth rate | 1.58 | None |
Start of sampling (No. of fish) | 686 | None |
Tank code | SC02 | None |
The thermal growth coefficient | 1.46 | None |
Total end of sampling biomass | 1111 | g |
Total end weight | 35378 | g |
Total mid sampling biomass | 189 | g |
Total start biomass | 11147 | g |
Marker | Measurement | Units |
---|---|---|
Analyzed Energy (bomb calorimetry) | 22.2 | MJ/kg |
Analyzed Fat | 19.8 | None |
Analyzed Moisture | 0.3 | % |
Analyzed Protein | 53 | None |
Fish Meal | 41.33 | % |
Fish Oil | 8.311 | % |
Protein concentrate | 23.044 | % |
Rapeseed Oil | 8.311 | % |
Sanford Blue Mussel Ensilage | 5 | % |
Target Energy (crude) | 19.8 | MJ/kg |
Target Fat | 21.7 | None |
Target Moisture | 6.5 | % |
Target Protein (crude) | 48.9 | % |
Treatment code | Orn | None |
Treatment concentration | 5.0% | % |
Treatment description | Ensilaged blue mussel protein | None |
Vit + min + AA | 1.576 | % |
Wheat | 12.408 | % |
Yttrium | 0.02 | % |
Marker | Measurement | Units |
---|---|---|
Sum 16:1 | 1,57 | mg/g |
Sum 18:1 | 8,44 | mg/g |
Sum 20:1 | 2,05 | mg/g |
Sum 22:1 | 1,47 | mg/g |
Sum EPA+DHA | 6,03 | mg/g |
Sum fatty acids | 32,2 | mg/g |
Sum identified | 31,5 | mg/g |
Sum monounsaturate | 13,7 | mg/g |
Sum n-3 | 8,36 | mg/g |
Sum n-6 | 2,82 | mg/g |
Sum polyunsaturated | 11,3 | mg/g |
Sum saturated | 6,53 | mg/g |
Sum unidentified | 0,682 | mg/g |
16:2n-4 | 0,10 | mg/g |
16:4n-3 | <0.01 | mg/g |
18:1n-11 | 0,27 | mg/g |
21:5n-3 | 0,10 | mg/g |
22:1n-11 | 1,25 | mg/g |
Adrenic acid 22:4n-6 | <0.01 | mg/g |
Alpha-Linolenic acid 18:3n-3 | 0,80 | mg/g |
Arachidic acid 20:0 | 0,03 | mg/g |
Arachidonic acid 20:4n-6 (ARA) | 0,21 | mg/g |
Behenic acid 22:0 | <0.01 | mg/g |
Capric acid 10:0 | <0.01 | mg/g |
Caproic acid 6:0 | <0.01 | mg/g |
Caprylic acid 8:0 | <0.01 | mg/g |
Di-homo-gamma-linolenic acid 20:3n-6 | 0,09 | mg/g |
Docosahexaenoic acid 22:6n-3 (DHA) | 4,97 | mg/g |
Docosapentaenoic acid 22:5n-3 (DPA) | 0,44 | mg/g |
Eicosadienoic acid 20:2n-6 | 0,17 | mg/g |
Eicosapentaenoic acid 20:5n-3 (EPA) | 1,06 | mg/g |
Eicosatetraenoic acid 20:4n-3 | 0,26 | mg/g |
Eicosatrienoic acid 20:3n-3 | <0.01 | mg/g |
Eicosenoic acid 20:1n-9 | 1,83 | mg/g |
Erucic acid 22:1n-9 | 0,22 | mg/g |
Gadoleic acid 20:1n-11 | 0,16 | mg/g |
Gamma-Linolenic acid 18:3n-6 | 0,04 | mg/g |
Hexadecatrienoic acid 16:3n-3 | <0.01 | mg/g |
Hypogeic acid 16:1n-9 | 0,13 | mg/g |
Lauric acid 12:0 | <0.01 | mg/g |
Lignoceric acid 24:0 | <0.01 | mg/g |
Linoleic acid 18:2n-6 | 2,25 | mg/g |
Margaric acid 17:0 | <0.01 | mg/g |
Mead acid 20:3n-9 | <0.01 | mg/g |
Myristic acid 14:0 | 1,08 | mg/g |
Myristoleic acid 14:1n-9 | <0.01 | mg/g |
Nervonic acid 24:1n-9 | 0,11 | mg/g |
Oleic acid 18:1n-9 | 6,95 | mg/g |
Osbond acid 22:5n-6 | 0,06 | mg/g |
Palmitic acid 16:0 | 4,39 | mg/g |
Palmitoleic acid 16:1n-7 | 1,44 | mg/g |
Paullinic acid 20:1n-7 | 0,06 | mg/g |
Pentadecylic acid 15:0 | 0,08 | mg/g |
Stearic acid 18:0 | 0,95 | mg/g |
Stearidonic acid 18:4n-3 | 0,42 | mg/g |
Tetracosahexaenoic acid 24:6n-3 | 0,21 | mg/g |
Tetracosapentaenoic acid 24:5n-3 | 0,10 | mg/g |
Vaccenic acid 18:1n-7 | 1,22 | mg/g |
n-3/n-6 | 1,5 | mg/g |
n-6/n-3 | 0,7 | mg/g |
Marker | Measurement | Units |
---|---|---|
Sum 16:1 | 1,57 | % |
Sum 18:1 | 8,44 | % |
Sum 20:1 | 2,05 | % |
Sum 22:1 | 1,47 | % |
Sum EPA+DHA | 6,03 | % |
Sum fatty acids | 32,2 | % |
Sum identified | 31,5 | % |
Sum monounsaturate | 13,7 | % |
Sum n-3 | 8,36 | % |
Sum n-6 | 2,82 | % |
Sum polyunsaturated | 11,3 | % |
Sum saturated | 6,53 | % |
Sum unidentified | 0,682 | % |
16:2n-4 | 0,10 | % |
16:4n-3 | <0.01 | % |
18:1n-11 | 0,27 | % |
21:5n-3 | 0,10 | % |
22:1n-11 | 1,25 | % |
Adrenic acid 22:4n-6 | <0.01 | % |
Alpha-Linolenic acid 18:3n-3 | 0,80 | % |
Arachidic acid 20:0 | 0,03 | % |
Arachidonic acid 20:4n-6 (ARA) | 0,21 | % |
Behenic acid 22:0 | <0.01 | % |
Capric acid 10:0 | <0.01 | % |
Caproic acid 6:0 | <0.01 | % |
Caprylic acid 8:0 | <0.01 | % |
Di-homo-gamma-linolenic acid 20:3n-6 | 0,09 | % |
Docosahexaenoic acid 22:6n-3 (DHA) | 4,97 | % |
Docosapentaenoic acid 22:5n-3 (DPA) | 0,44 | % |
Eicosadienoic acid 20:2n-6 | 0,17 | % |
Eicosapentaenoic acid 20:5n-3 (EPA) | 1,06 | % |
Eicosatetraenoic acid 20:4n-3 | 0,26 | % |
Eicosatrienoic acid 20:3n-3 | <0.01 | % |
Eicosenoic acid 20:1n-9 | 1,83 | % |
Erucic acid 22:1n-9 | 0,22 | % |
Gadoleic acid 20:1n-11 | 0,16 | % |
Gamma-Linolenic acid 18:3n-6 | 0,04 | % |
Hexadecatrienoic acid 16:3n-3 | <0.01 | % |
Hypogeic acid 16:1n-9 | 0,13 | % |
Lauric acid 12:0 | <0.01 | % |
Lignoceric acid 24:0 | <0.01 | % |
Linoleic acid 18:2n-6 | 2,25 | % |
Margaric acid 17:0 | <0.01 | % |
Mead acid 20:3n-9 | <0.01 | % |
Myristic acid 14:0 | 1,08 | % |
Myristoleic acid 14:1n-9 | <0.01 | % |
Nervonic acid 24:1n-9 | 0,11 | % |
Oleic acid 18:1n-9 | 6,95 | % |
Osbond acid 22:5n-6 | 0,06 | % |
Palmitic acid 16:0 | 4,39 | % |
Palmitoleic acid 16:1n-7 | 1,44 | % |
Paullinic acid 20:1n-7 | 0,06 | % |
Pentadecylic acid 15:0 | 0,08 | % |
Stearic acid 18:0 | 0,95 | % |
Stearidonic acid 18:4n-3 | 0,42 | % |
Tetracosahexaenoic acid 24:6n-3 | 0,21 | % |
Tetracosapentaenoic acid 24:5n-3 | 0,10 | % |
Vaccenic acid 18:1n-7 | 1,22 | % |
n-3/n-6 | 1,5 | % |
n-6/n-3 | 0,7 | % |
Marker | Measurement | Units |
---|---|---|
Environment | Tanks (flow-through) | None |
Trial code | SC | None |
Trial description | Trial C: Blue mussel ensilage-dose response | None |
Trial end | 2021-05-27 | None |
Trial start | 2021-03-09 | None |